BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yau T, Chan P, Epstein R, Poon RT. Evolution of systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol 2008; 14(42): 6437-6441 [PMID: 19030192 DOI: 10.3748/wjg.14.6437]
URL: https://www.wjgnet.com/1007-9327/full/v14/i42/6437.htm
Number Citing Articles
1
Xiaoyun Dai, Kwang Seok Ahn, Ling Zhi Wang, Chulwon Kim, Amudha Deivasigamni, Frank Arfuso, Jae-Young Um, Alan Prem Kumar, Young-Chae Chang, Dhiraj Kumar, Gopal C. Kundu, Junji Magae, Boon Cher Goh, Kam Man Hui, Gautam Sethi. Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular CarcinomaMolecular Cancer Therapeutics 2016; 15(12): 2966 doi: 10.1158/1535-7163.MCT-16-0391
2
Gaetano Bertino, Isidoro Di Carlo, Annalisa Ardiri, Giuseppe Stefano Calvagno, Shirin Demma, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera, Adriana Toro, Michele Malaguarnera. Systemic therapies in hepatocellular carcinoma: present and futureFuture Oncology 2013; 9(10): 1533 doi: 10.2217/fon.13.171
3
Qin-Sheng Dai, Wei Liu, Xiao-Bing Wang, Na Lu, Dan-Dan Gong, Ling-Yi Kong, Qing-Long Guo. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cellsAnti-Cancer Drugs 2011; 22(1): 46 doi: 10.1097/CAD.0b013e3283405801
4
Mathieu Bergé, Philippe Bonnin, Eric Sulpice, José Vilar, David Allanic, Jean-Sébastien Silvestre, Bernard I. Lévy, Gordon C. Tucker, Gérard Tobelem, Tatyana Merkulova-Rainon. Small Interfering RNAs Induce Target-Independent Inhibition of Tumor Growth and Vasculature Remodeling in a Mouse Model of Hepatocellular CarcinomaThe American Journal of Pathology 2010; 177(6): 3192 doi: 10.2353/ajpath.2010.100157
5
Eva M. Molina-Trinidad, Consuelo Arteaga De Murphy, Helgi Jung-Cook, Eduardo Murphy Stack, Martha Pedraza-Lopez, José Luis Morales-Marquez, Guadalupe Vertiz Serrano. Therapeutic188Re-lanreotide: determination of radiopharmacokinetic parameters in ratsJournal of Pharmacy and Pharmacology 2010; 62(4): 456 doi: 10.1211/jpp.62.04.0007
6
Sudeep Tanwar, Shahid A Khan, Vijay Paul Bob Grover, Catherine Gwilt, Belinda Smith, Ashley Brown. Liver transplantation for hepatocellular carcinomaWorld Journal of Gastroenterology 2009; 15(44): 5511-5516 doi: 10.3748/wjg.15.5511
7
Stefan Buchkremer, Jasmin Hendel, Markus Krupp, Arndt Weinmann, Kai Schlamp, Thorsten Maass, Frank Staib, Peter R Galle, Andreas Teufel. Library of molecular associations: curating the complex molecular basis of liver diseasesBMC Genomics 2010; 11(1) doi: 10.1186/1471-2164-11-189
8
O. Abdel-Rahman, Z. A. Elsayed. Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the LiteratureDigestive Diseases and Sciences 2013; 58(12): 3389 doi: 10.1007/s10620-013-2872-x
9
Bing Hu, Shuang-Shuang Wang, Qin Du. Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedsideWorld Journal of Hepatology 2015; 7(9): 1209-1232 doi: 10.4254/wjh.v7.i9.1209
10
Yin-Hsun Feng, Cheng-Yao Lin, Wen-Tsung Huang, Chia-Ling Wu, Jui-Lung Fang, Chao-Jung Tsao. Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinomaMedical Oncology 2011; 28(4): 1080 doi: 10.1007/s12032-010-9650-9
11
Emad F. Eskander, Ahmed A. Abd-Rabou, Shaymaa M. M. Yahya, Ashraf El Sherbini, Mervat S. Mohamed, Olfat G. Shaker. Correlation and Multiple Regression Analyses of Pituitary Growth Hormone and Hepatic Activities in Hepatitis C Infection and Interferon ResponseIndian Journal of Clinical Biochemistry 2013; 28(4): 348 doi: 10.1007/s12291-013-0309-0
12
Ramona Rudalska, Daniel Dauch, Thomas Longerich, Katherine McJunkin, Torsten Wuestefeld, Tae-Won Kang, Anja Hohmeyer, Marina Pesic, Josef Leibold, Anne von Thun, Peter Schirmacher, Johannes Zuber, Karl-Heinz Weiss, Scott Powers, Nisar P Malek, Martin Eilers, Bence Sipos, Scott W Lowe, Robert Geffers, Stefan Laufer, Lars Zender. In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancerNature Medicine 2014; 20(10): 1138 doi: 10.1038/nm.3679
13
Omar M Abdel-Rahman, Zeinab Elsayed. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinomaCochrane Database of Systematic Reviews 2016;  doi: 10.1002/14651858.CD011313.pub2
14
Ahmed Ebraheem Ebeed, Marwa Abd El-hamied Romeih, Medhat Mohamed Refat, Mohamed Hamdy Yossef. Role of dynamic contrast-enhanced and diffusion weighted MRI in evaluation of hepatocellular carcinoma after chemoembolizationThe Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 807 doi: 10.1016/j.ejrnm.2017.06.006
15
Kevin Tak-Pan Ng, Aimin Xu, Qiao Cheng, Dong Yong Guo, Zophia Xue-Hui Lim, Chris Kin-Wai Sun, Jeffrey Hon-Sing Fung, Ronnie Tung-Ping Poon, Sheung Tat Fan, Chung Mau Lo, Kwan Man. Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinomaMolecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-196
16
Omar Abdel-Rahman, Zeinab Elsayed. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinomaCochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD011313.pub3
17
Thomas Yau, Pierre Chan, Roberta Pang, Kelvin Ng, S. T. Fan, Ronnie T. Poon. Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinomaCancer 2010; 116(21): 5022 doi: 10.1002/cncr.25372
18
Omar Abdel-Rahman, Zeinab Elsayed. External beam radiotherapy for unresectable hepatocellular carcinomaCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD011314.pub2
19
Soo Hyung Ryu, Young-Hwa Chung. How to overcome multidrug resistance in chemotherapy for advanced hepatocellular carcinomaLiver International 2010; 30(4): 496 doi: 10.1111/j.1478-3231.2010.02215.x
20
Xue-Wei Yang, Xiao-Li Wang, Liang-Qi Cao, Xiao-Feng Jiang, He-Ping Peng, Shao-Mang Lin, Ping Xue, De Chen. Green tea polyphenol epigallocatechin-3-gallate enhances 5-fluorouracil-induced cell growth inhibition of hepatocellular carcinoma cellsHepatology Research 2012; 42(5): 494 doi: 10.1111/j.1872-034X.2011.00947.x
21
Xiaoxuan Liu, Lin Zhu, Jingjing Ma, Xinxiao Qiao, Dunwan Zhu, Lanxia Liu, Xigang Leng. Target-specific delivery of siRNA into hepatoma cells’ cytoplasm by bifunctional carrier peptideDrug Delivery and Translational Research 2017; 7(1): 147 doi: 10.1007/s13346-016-0348-1
22
Nancy Kilcup, Elena Tonkopi, Robert J Abraham, Daniel Boyd, Sharon Kehoe. Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolizationJournal of Biomaterials Applications 2015; 30(1): 93 doi: 10.1177/0885328215572196
23
Christian Steinberg, Suzanne Boudreau, Felix Leveille, Marc Lamothe, Patrick Chagnon, Isabelle Boulais. Advanced Hepatocellular Carcinoma with Subtotal Occlusion of the Inferior Vena Cava and a Right Atrial MassCase Reports in Vascular Medicine 2013; 2013: 1 doi: 10.1155/2013/489373
24
Wei Jiang, Zhiming Wang, Xinying Li, Jindong Li, Yun Huang, Xuegong Fan, Yankun Duan. Reduced High-Mobility Group Box 1 Expression Induced by RNA Interference Inhibits the Bioactivity of Hepatocellular Carcinoma Cell Line HCCLM3Digestive Diseases and Sciences 2012; 57(1): 92 doi: 10.1007/s10620-011-1944-z
25
Judith Ertle, Alexander Dechêne, Jan-Peter Sowa, Volker Penndorf, Kerstin Herzer, Gernot Kaiser, Jörg F. Schlaak, Guido Gerken, Wing-Kin Syn, Ali Canbay. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosisInternational Journal of Cancer 2011; 128(10): 2436 doi: 10.1002/ijc.25797
26
Mona Fouad, Omar Abdel-Rahman. Combination of transarterial chemoembolisation (TACE) plus antivirals for the management of hepatitis B-related hepatocellular carcinoma: A systematic review of the literatureArab Journal of Gastroenterology 2015; 16(2): 40 doi: 10.1016/j.ajg.2015.03.003
27
Parsia A. Vagefi, Ryutaro Hirose. Downstaging of Hepatocellular Carcinoma Prior to Liver Transplant: Is There a Role for Adjuvant Sorafenib in Locoregional Therapy?Journal of Gastrointestinal Cancer 2010; 41(4): 217 doi: 10.1007/s12029-010-9163-y
28
Iván Lyra-González, Laura Esther Flores-Fong, Ignacio González-García, David Medina-Preciado, Juan Armendáriz-Borunda. Adenoviral gene therapy in hepatocellular carcinoma: a reviewHepatology International 2013; 7(1): 48 doi: 10.1007/s12072-012-9367-2
29
Ming-Liang You, Yi-Jun Chen, Qing-Yun Chong, Ming-Ming Wu, Vijay Pandey, Ru-Mei Chen, Liang Liu, Lan Ma, Zheng-Sheng Wu, Tao Zhu, Peter E. Lobie. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependentOncotarget 2017; 8(24): 39323 doi: 10.18632/oncotarget.16950
30
Gaetano Bertino, Shirin Demma, Annalisa Ardiri, Maria Proiti, Giulia Malaguarnera, Nicoletta Bertino, Michele Malaguarnera, Mariano Malaguarnera. Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future TherapiesBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/203693
31
Omar M Abdel-Rahman, Zeinab Elsayed, Omar M Abdel-Rahman. Cochrane Database of Systematic Reviews2014;  doi: 10.1002/14651858.CD011314
32
HUIWEN HU, CHENGYONG TANG, QINGHU JIANG, WEI LUO, JIMING LIU, XUFU WEI, RUI LIU, ZHONGJUN WU. Reduced ubiquitin-specific protease 9X expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cellsOncology Letters 2015; 10(1): 268 doi: 10.3892/ol.2015.3152
33
Ramona Rudalska, Jule Harbig, Marteinn T. Snaebjornsson, Sabrina Klotz, Stefan Zwirner, Liudmyla Taranets, Florian Heinzmann, Thales Kronenberger, Michael Forster, Wei Cui, Luana D’Artista, Elias Einig, Martina Hinterleitner, Werner Schmitz, Agata Dylawerska, Tae-Won Kang, Antti Poso, Mathias T. Rosenfeldt, Nisar P. Malek, Michael Bitzer, Stefan Laufer, Bernd J. Pichler, Nikita Popov, Almut Schulze, Lars Zender, Daniel Dauch. LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerNature Cancer 2021; 2(2): 201 doi: 10.1038/s43018-020-00168-3
34
Claire Legendre, Tamaki Hori, Pascal Loyer, Caroline Aninat, Seiichi Ishida, Denise Glaise, Catherine Lucas-Clerc, Karim Boudjema, Christiane Guguen-Guillouzo, Anne Corlu, Fabrice Morel. Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1α involvement in CYP3A4 repressionEuropean Journal of Cancer 2009; 45(16): 2882 doi: 10.1016/j.ejca.2009.07.010
35
Chunguang Wang, Wei Gao, Mingqian Feng, Ira Pastan, Mitchell Ho. Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapyOncotarget 2017; 8(20): 32450 doi: 10.18632/oncotarget.10592
36
Bruno Sangro, Riad Salem, Andrew Kennedy, Douglas Coldwell, Harpreet Wasan. Radioembolization for Hepatocellular CarcinomaAmerican Journal of Clinical Oncology 2011; 34(4): 422 doi: 10.1097/COC.0b013e3181df0a50
37
Bing Hu, Hong-Mei An, Shuang-Shuang Wang, Jin-Jun Chen, Ling Xu. Preventive and Therapeutic Effects of Chinese Herbal Compounds against Hepatocellular CarcinomaMolecules 2016; 21(2): 142 doi: 10.3390/molecules21020142
38
Kevin Tak-Pan Ng, Chung Mau Lo, Dong Yong Guo, Xiang Qi, Chang Xian Li, Wei Geng, Xiao Bing Liu, Chang Chun Ling, Yuen Yuen Ma, Wai Ho Yeung, Yan Shao, Ronnie Tung-Ping Poon, Sheung Tat Fan, Kwan Man. Identification of Transmembrane Protein 98 as a Novel Chemoresistance-Conferring Gene in Hepatocellular CarcinomaMolecular Cancer Therapeutics 2014; 13(5): 1285 doi: 10.1158/1535-7163.MCT-13-0806
39
Niraj J. Gusani, Yixing Jiang, Eric T. Kimchi, Kevin F. Staveley-OʼCarroll, Hua Cheng, Jaffer A. Ajani. New Pharmacological Developments in the Treatment of Hepatocellular CancerDrugs 2009; 69(18): 2533 doi: 10.2165/11530870-000000000-00000
40
Omar M Abdel-Rahman, Zeinab Elsayed, Omar M Abdel-Rahman. Cochrane Database of Systematic Reviews2014;  doi: 10.1002/14651858.CD011313
41
Min Ding, Jiang Li, Yong Yu, Hui Liu, Zi Yan, Jinghan Wang, Qijun Qian. Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cellsJournal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0609-7
42
T. J. Grant, J. A. Bishop, L. M. Christadore, G. Barot, H. G. Chin, S. Woodson, J. Kavouris, A. Siddiq, R. Gredler, X.-N. Shen, J. Sherman, T. Meehan, K. Fitzgerald, S. Pradhan, L. A. Briggs, W. H. Andrews, D. Sarkar, S. E. Schaus, U. Hansen. Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinomaProceedings of the National Academy of Sciences 2012; 109(12): 4503 doi: 10.1073/pnas.1121601109